Treatment Patterns in Metastatic Bladder Cancer in Japan: Results of the CancerMPact <sup>®</sup> Survey 2020-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment Patterns in Metastatic Bladder Cancer in Japan: Results of the CancerMPact ^® Survey 2020

Published:2024-03 Issue:10 Volume:20 Page:603-611
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncol.

Author:

A Bueno Ana Paula¹^ORCID,Clark Otavio²^ORCID,Turnure Matthew²^ORCID,Moreira Eloisa S¹,Yuasa Akira³^ORCID,Sugiyama Shigeru³,Kirker Melissa⁴,Li Si⁴,Hou Ningqi⁴,Chang Jane⁴,Kearney Mairead⁵,Kanas Gena²^ORCID

Affiliation:

1. Cerner Enviza, An Oracle Company, Av. das Nações Unidas 14171 15º andar, Morumbi São Paulo/SP CEP, 04794-000, Brazil

2. Cerner Enviza, An Oracle Company, 2300 Oracle Wy, Austin, TX 78741, USA

3. Pfizer Japan Inc, 3-22-7 Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan

4. Pfizer Inc, 235 E 42nd St, New York, NY 10017, USA

5. Merck Healthcare KGaA, Frankfurter Strasse 250 Darmstadt, 64293, Germany

Funder

Merck

Cerner Enviza

Pfizer

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/fon-2023-0197

Reference24 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Impact of sex difference on survival of bladder cancer: A population‐based registry data in Japan

3. Cancer statistics, 2019

4. Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

5. Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP